SERPINE1 and COVID-19: Given the critical participation of TMPRSS2 and SERPINE1 in SARS-CoV-2 infection, it is relevant to investigate whether their genetic variants could be associated with the severity of clinical manifestations and/or fatal outcomes in COVID-19 patients.